Key Highlights

  • Texas Instruments delivered Q1 2026 EPS of $1.68, surpassing the $1.36 consensus estimate
  • Quarterly revenue reached $4.83 billion, exceeding the anticipated $4.52 billion
  • Industrial business expanded over 20% sequentially; Data Center jumped over 25%
  • Barclays moved TXN to Equalweight from Underweight, increasing its target from $175 to $250
  • Several analysts lifted their targets, with KeyBanc reaching $325 and Rosenblatt hitting $330

Texas Instruments delivered a robust performance in the opening quarter of 2026, surpassing Wall Street projections across key metrics. Earnings per share reached $1.68, significantly above the $1.36 Street estimate. Quarterly sales totaled $4.83 billion compared to forecasts of $4.52 billion.

Shares rallied approximately 16% following the announcement, climbing from roughly $233 to approximately $274.


TXN Stock Card
Texas Instruments Incorporated, TXN

The quarterly performance benefited from robust momentum across two critical business lines: Industrial and Data Center. The Industrial segment expanded more than 20% sequentially during March. Data Center operations grew more than 25% during the comparable timeframe.

Management’s Q2 outlook came in modestly ahead of typical seasonal patterns, suggesting sustained momentum in both segments. Automotive demand continued to show variability, per UBS commentary.

Wall Street Responds with Upgrades and Higher Targets

Barclays executed the most significant rating adjustment, moving TXN from Underweight to Equalweight while boosting its price objective from $175 to $250. The firm attributed the revision to strengthening fundamentals in Industrial and Data Center operations.

Barclays projects Data Center revenue will expand more than 90% across the full 2026 calendar year. The firm anticipates Industrial will again outperform typical seasonal patterns in the June quarter.

The firm’s updated financial model estimates $10 per share in free cash flow for TXN during calendar 2027. Current Wall Street consensus sits around $8.55 per share.

UBS maintained its Buy recommendation while increasing its price objective from $260 to $295. The firm noted results aligned with heightened market expectations, with forward guidance providing a modest upside.

Cantor Fitzgerald lifted its target from $250 to $280 while maintaining a Neutral stance. The firm applied an elevated 28x valuation multiple compared to its prior 25x framework, acknowledging improving fundamentals within analog semiconductors.

Additional Analyst Commentary

KeyBanc established the highest price objective among major firms, raising its target to $325. BofA Securities moved its rating to Buy with a $320 target, highlighting strength in aerospace and defense applications within the industrial portfolio.

Rosenblatt increased its price objective to $330. Baird adjusted its target to $300. Wolfe Research, which observed Q1 revenue climbing 9% sequentially, established a $315 target.

TXN currently commands approximately 26 times free cash flow, elevated compared to its historical mid-teens valuation range. The price-to-earnings ratio stands at 43.15.

Barclays noted that the company still faces execution challenges regarding Street projections for the year’s latter half. Cantor Fitzgerald highlighted ongoing uncertainties surrounding memory supply constraints and geopolitical factors as reasons for maintaining selectivity across the broader semiconductor sector.

Shares traded near $274, approaching the previous 52-week high of $238.80 established before the earnings-driven rally.